Skip to content

Flash Glucose Monitoring: an alternative screening method for Gestational Diabetes Mellitus?

Flash Glucose Monitoring: an alternative screening method for Gestational Diabetes Mellitus? - FGM: an alternative screening method for GDM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55968
Enrollment
20
Registered
2023-09-20
Start date
2023-10-25
Completion date
Unknown
Last updated
2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GDM gestational diabetes

Interventions

As part of diagnostic research, an FGM will be placed in addition to the standard OGTT (placement is an act). The subject will then scan the sensor every 8 hours for 7 days (there may be more than 8

Sponsors

Gelre Ziekenhuizen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Adult woman between 24 and 28 weeks of pregnancy who is eligible for an OGTT in primary obstetric care according to the guideline of the Dutch Society of Obstetrics & Gynaecology

Exclusion criteria

Exclusion criteria: Diabetes mellitus in history Pregnant women in 2nd and 3rd line obstetric/gynaecological care.

Design outcomes

Primary

MeasureTime frame
Outcomes: - Gestational age at start FGM in weeks + days - Time above target range (>7.8 mmol/l) in percent. Where >1% is abnormal. - Active sensor in percent minimum 80% active sensor needed for reliable image - FGM diagnosis GDM yes/no - Gestational age at taking OGTT, in weeks + days - OGTT result fasting capillary glucose in mmol/l - Result OGTT two-hour capillary glucose value in mmol/l - OGTT diagnosis GDM yes/no

Secondary

MeasureTime frame
Patient characteristics - Age in years at first antenatal check-up - BMI at first antenatal check-up in kg/m2 - How many pregnancy - À terme date - Indication OGTT - Evidencio score in percent rounded to one decimal point. This is a prediction model which calculates the pregnant person's risk of developing GDM and is calculated in the first trimester of pregnancy

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)